Based on China’s 2022 Guidelines and our hospital’s laboratory standards, which use 40 U/L as the ALT normal threshold, this study aimed to evaluate the virological response to antiviral therapy in chronic HBV-related liver disease patients with low ALT levels and high viral loads. The gene discussed is GPT; the disease is liver disorder.